Khaleel et al. [77] found that SFN improved streptozotocin−induced diabetic nephropathy by upregulating Nrf2 and HO−1 genes and downregulating IL−6 and caspase−3 genes. The gene discussed is IL6; the disease is diabetic kidney disease.